How Schaefer was paid
$499,477 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Stanley E. Jacot, Jr.Former President and Chief Executive Officer | $230,031 | — | — | — | $288,077 | $518,108 |
| Thomas J. SchaeferPresident and Chief Executive Officer | $260,000 | $65,000 | $43,888 | $126,853 | $3,736 | $499,477 |
| Mark KawakamiFormer Chief Financial Officer | $212,742 | $53,016 | $43,888 | $57,802 | $2,727 | $370,175 |
| Laura PitlikFormer Chief Marketing Officer | $88,942 | — | — | — | $65,885 | $154,826 |
What changed and why
- $499KThomas J. Schaefer total compensation increased to $499,477 following his appointment as chief executive officer.
- $288KStanley E. Jacot, Jr. received a severance payment of $288,077 after resigning as president and chief executive officer.
- $370KMark Kawakami received a total compensation of $370,175 for serving as former chief financial officer.
- $65,885Laura Pitlik received severance compensation of $65,885 following her departure as chief marketing officer.
Other Arcadia Biosciences proxy statements
- 2026 proxy statement
Thomas J. Schaefer paid $469,001 (-6% on the year).
Filed Aug 10, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.